Stock Price
74.12
Daily Change
0.34 0.46%
Monthly
-0.75%
Yearly
-19.89%
Q1 Forecast
71.27

Symrise reported EUR2.08B in Operating Expenses for its fiscal semester ending in December of 2024.





Operating Expenses Change Date
Avient USD 739.4M 31M Sep/2025
Chemours USD 1.33B 71M Dec/2025
Corteva USD 3.1B 217M Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Symrise EUR 2.08B 118.33M Dec/2024
Victrex GBP 123.9M 200K Dec/2025